Posts Tagged ‘therapy’
Can the hyperbaric oxygen therapy helps to reduce the tolerance to glucose ( diabetes type 2 ) ?
My current glucose level is among 110 to 120 in blood after 12 hours of ayune. Hence my dad was diabetic, I want to search alternative methods to prevent the glucose level going up to 126 or plus, though I’m currently under treatment of Metformina 750 slow release for about 4 months already.
Thank you for sharing your experience.
Yes, I actually mean ” tolerance to insulin ” Thanks
{answer}
Amylin, JDRF collaborate to investigate combination therapy for type 1 diabetes treatment
Amylin, JDRF collaborate to investigate combination therapy for type 1 diabetes treatment
The Juvenile Diabetes Research Foundation and Amylin Pharmaceuticals, Inc. announced today that they have entered into a research collaboration agreement to provide financial support for a series of clinical studies to investigate the feasibility of mixing pramlintide, an analog of the human hormone amylin, with insulin to treat type 1 diabetes.
Read more on News-Medical-Net
Stem Cell Therapy for Type II Diabetes
www.cellmedicine.com
Study finds antibiotic safe for treatment of stroke and good companion therapy for tPA
Study finds antibiotic safe for treatment of stroke and good companion therapy for tPA
An antibiotic appears to be a safe treatment for stroke and a good companion therapy for tPA, the clot buster that is currently the only FDA-approved drug therapy, researchers report.
Insulin therapy study recruits 60,000 patients
Insulin therapy study recruits 60,000 patients
Kolkata, July 20 : Novo Nordisk, a leading healthcare company, on Tueesday announced the recruitment of the 60,000th patient in the A1chieve study – an observational study designed to investigate the effects of modern insulins in the management of type 2 diabetes.
Successful amylin replacement therapy for your type 2 diabetes patients
Listen to Patrick Boyle, MD, lead physician of Diabetes Care Management at the University of New Mexico and a well-known endocrinologist thought leader, provide the key elements for successful pramlintide initiation and titration for your type 1 diabetes patients, as well as some clinical pearls on how to avoid the various barriers and pitfalls you may encounter. Provided by the Institute for Diabetes, Obesity, and Cardiovascular Disease (iDOC), a free resource for continuing medical education and other tools for medical professionals focused on the treatment of these three related conditions. Visit www.idoc.org for more information.